0001553846-19-000003.txt : 20191106 0001553846-19-000003.hdr.sgml : 20191106 20191106143435 ACCESSION NUMBER: 0001553846-19-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20191106 DATE AS OF CHANGE: 20191106 EFFECTIVENESS DATE: 20191106 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RedHill Biopharma Ltd. CENTRAL INDEX KEY: 0001553846 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-352751 FILM NUMBER: 191195966 BUSINESS ADDRESS: STREET 1: 21 HA'ARBA'A STREET CITY: TEL AVIV STATE: L3 ZIP: 64739 BUSINESS PHONE: 972-3-541-3131 MAIL ADDRESS: STREET 1: 21 HA'ARBA'A STREET CITY: TEL AVIV STATE: L3 ZIP: 64739 D 1 primary_doc.xml X0708 D LIVE 0001553846 RedHill Biopharma Ltd. 21 HA'ARBA'A STREET TEL AVIV L3 ISRAEL 6473921 972-3-541-3131 ISRAEL None None Corporation true Dror Ben-Asher 21 HA'ARBA'A STREET TEL AVIV L3 ISRAEL 6473921 Executive Officer Director Eric Swenden 21 HA'ARBA'A STREET TEL AVIV L3 ISRAEL 6473921 Director Kenneth Reed 21 HA'ARBA'A STREET TEL AVIV L3 ISRAEL 6473921 Director Ofer Tsimchi 21 HA'ARBA'A STREET TEL AVIV L3 ISRAEL 6473921 Director Shmuel Cabilly 21 HA'ARBA'A STREET TEL AVIV L3 ISRAEL 6473921 Director Rick D Scruggs 21 HA'ARBA'A STREET TEL AVIV L3 ISRAEL 6473921 Executive Officer Director Nicolas Weinstein 21 HA'ARBA'A STREET TEL AVIV L3 ISRAEL 6473921 Director Alla Felder 21 HA'ARBA'A STREET TEL AVIV L3 ISRAEL 6473921 Director Micha Ben Chorin 21 HA'ARBA'A STREET TEL AVIV L3 ISRAEL 6473921 Executive Officer Adi Frish 21 HA'ARBA'A STREET TEL AVIV L3 ISRAEL 6473921 Executive Officer Gilead Raday 21 HA'ARBA'A STREET TEL AVIV L3 ISRAEL 6473921 Executive Officer Guy Goldberg 21 HA'ARBA'A STREET TEL AVIV L3 ISRAEL 6473921 Executive Officer Reza Fathi 21 HA'ARBA'A STREET TEL AVIV L3 ISRAEL 6473921 Executive Officer June Almenoff 21 HA'ARBA'A STREET TEL AVIV L3 ISRAEL 6473921 Executive Officer Pharmaceuticals $5,000,001 - $25,000,000 06b false 2019-10-22 false true false 0 48300000 48300000 0 A portion of the ADSs were issued at an agreed value of $12 million, as an upfront payment for rights granted to the issuer under an exclusive license agreement false 2 0 0 0 false RedHill Biopharma Ltd. /s/ Micha Ben Chorin Micha Ben Chorin CFO 2019-11-06